Mashimo K, Homma J Y, Iki Y, Inatomi K, Kasai T, Kunii O, Shimada K, Tanimoto H, Takigami T, Nishimura Y
Jpn J Exp Med. 1981 Oct;51(5):271-85.
The combined effect of beta-lactam antibiotics and 9,3"-di-O-acetylmidecamycin were examined in 10 patients diagnosed as having chronic respiratory tract infections and complicated urinary tract infections. Patients were initially treated with 3 to 10 g/day of beta-lactams as intravenous infusions or by oral route for a certain period, after which period they were treated concurrently with 0.3 to 0.9 g/day of 9,3"-di-O-acetylmidecamycin by oral route. Through this combination therapy eradication of P. aeruginosa was obtained in 2 cases and remarkable decrease in another 2 cases out of the 10 cases. This combination therapy was judged to be effective in these 4 cases. Of the remaining cases, P. aeruginosa was eliminated before the start of the combination therapy in 3 cases, and no change in bacterial count was noted after the combination therapy in the other 3 cases.
对10例诊断为慢性呼吸道感染和复杂性尿路感染的患者,研究了β-内酰胺类抗生素与9,3”-二-O-乙酰麦迪霉素的联合效果。患者最初接受3至10克/天的β-内酰胺类药物静脉输注或口服治疗一段时间,之后同时接受0.3至0.9克/天的9,3”-二-O-乙酰麦迪霉素口服治疗。通过这种联合治疗,10例患者中有2例铜绿假单胞菌被根除,另外2例显著减少。判断这4例联合治疗有效。其余病例中,3例在联合治疗开始前铜绿假单胞菌已被清除,另外3例联合治疗后细菌计数无变化。